Genetic predisposition to prostate cancer
- PMID: 12496860
- DOI: 10.1038/sj.pcan.4500279
Genetic predisposition to prostate cancer
Abstract
Prostate cancer has been known to run in families for about 40 years and epidemiological studies have demonstrated an increased risk to close relatives of cases. This risk rises markedly when the closeness and number of cases in a cluster increases. There has been considerable debate about the genetic model, in particular whether there is a commoner lower penetrance (moderately increased risk of the disease due to the gene(s)) in addition to contribution from high risk genes. For the first time, molecular results are starting to emerge, indicating the location of high risk genes. These have shown that there is evidence for more than one site of a high risk, gene two sites on chromosome 1 and one on chromosome X. These do not account for all clusters of prostate cancer cases and further genes remain to be discovered. This article also outlines the contribution of the numerous collaborators in the British Prostate Group to the UK Familial Prostate Cancer Study.
Similar articles
-
Unravelling the genetics of prostate cancer.Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):65-73. doi: 10.1002/ajmg.c.30027. Am J Med Genet C Semin Med Genet. 2004. PMID: 15264274 Review.
-
Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):935-8. doi: 10.1158/1055-9965.EPI-05-0910. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16702373
-
Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.Cancer. 2003 Oct 1;98(7):1411-6. doi: 10.1002/cncr.11639. Cancer. 2003. PMID: 14508827
-
Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.Anticancer Res. 2003 May-Jun;23(3C):2897-902. Anticancer Res. 2003. PMID: 12926131
-
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. J Gynecol Obstet Biol Reprod (Paris). 2003. PMID: 12717301 Review. French.
Cited by
-
Review of prostate cancer genomic studies in Africa.Front Genet. 2022 Oct 11;13:911101. doi: 10.3389/fgene.2022.911101. eCollection 2022. Front Genet. 2022. PMID: 36303548 Free PMC article. Review.
-
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.J Clin Oncol. 2013 May 10;31(14):1748-57. doi: 10.1200/JCO.2012.43.1882. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569316 Free PMC article.
-
Prostate cancer: risk assessment and diagnostic approaches.Rev Urol. 2001;3 Suppl 2(Suppl 2):S31-8. Rev Urol. 2001. PMID: 16985998 Free PMC article.
-
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.Prostate Cancer Prostatic Dis. 2018 Jun;21(2):228-237. doi: 10.1038/s41391-017-0029-2. Epub 2018 Jan 3. Prostate Cancer Prostatic Dis. 2018. PMID: 29298992 Free PMC article.
-
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.Genet Med. 2015 Oct;17(10):789-95. doi: 10.1038/gim.2014.192. Epub 2015 Jan 8. Genet Med. 2015. PMID: 25569441 Free PMC article.
LinkOut - more resources
Full Text Sources